• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,180.72 -104.35
( -0.13%)
Global Indices
Nasdaq
52,927.94 -148.97
(-0.28%)
Dow Jones
7,522.05 -36.38
(-0.48%)
Hang Seng
68,399.59 -1,338.10
(-1.92%)
Nikkei 225
10,685.41 33.64
(0.32%)
Forex
USD-INR
95.19 -0.09
(-0.09%)
EUR-INR
108.86 0.10
(0.10%)
GBP-INR
127.02 0.03
(0.03%)
JPY-INR
0.59 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Hindustan Zinc Ltd
Industry :  Mining / Minerals / Metals
BSE Code
ISIN Demat
Book Value()
500188
INE267A01025
53.1914012
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HINDZINC
16.42
224258.81
EPS(TTM)
Face Value()
Div & Yield %
32.33
2
1.88
 

Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
May 13,2026
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12